Transport across the membrane of a cell is of crucial importance for cellular functions. The solute carrier family,SLC38 is a family of membrane proteins that transports various substances through the membrane and thusperforms many physiologically important functions, for example, transport of glutamine from astrocyte toneurons in the central nervous system. In this paper, we demonstrate that one of the transporters in this familynamed SLC38A6 forms several protein complexes with a variety of proteins in the membrane and in synapticvesicles, suggesting that SLC38A6 is involved in the synaptic release of neurotransmitters in synapses. Weperformed sensitive protein interaction analysis between the protein of interest and a variety of proteinsexpressed at different sites in the neuronal cell. We showed that SLC38A6 interacts with proteins in the cellmembrane as well as in the membrane of synaptic vesicles. The current theory is that SLC38A6 interact withthese proteins when the synaptic vesicles are in close proximity with the cell membrane during the release of theneurotransmitters.

Le myo-inositol (MI) est un soluté organique impliqué dans diverses fonctions physiologiques de la cellule dont la signalisation cellulaire. Il est également un osmolyte compatible reconnu. Trois co-transporteurs de type actif secondaire responsables de son absorption ont été identifiés. Deux d’entre eux sont couplés au transport du sodium (SMIT1 et SMIT2) et le troisième est couplé au transport de protons (HMIT). L’objectif de cette étude a été la caractérisation du transport du MI par SMIT2 dans des membranes en bordure en brosse (BBMv) issues du rein de lapin et de l’intestin de rat ainsi qu’après expression dans les ovocytes de Xenopus laevis. La quantification de l’ARNm de SMIT1 et de SMIT2 dans le rein nous a appris que SMIT1 est majoritairement présent dans la médullaire alors que SMIT2 est principalement localisé dans le cortex. Ces résultats ont été confirmés par immunobuvardage en utilisant un anticorps dirigé contre SMIT2. Grâce à l’inhibition sélective de SMIT1 par le L-Fucose et de SMIT2 par le D-chiro-inositol (DCI), nous avons démontré que SMIT2 semble le seul responsable du transport luminal de MI dans le tubule contourné proximal avec un Km de 57 ± 14 µM. Pour ce qui est de l’intestin, des études de transport de MI radioactif ont démontré une absence de transport de MI chez le lapin alors que l’intestin de rat présente un transport de MI très actif. Une quantification par qRT-PCR nous a permis de constater que l’intestin de lapin ne semble pas posséder les transporteurs de MI nécessaires. Comme pour le rein, SMIT2 semble le seul transporteur de MI présent au niveau du pôle apical des entérocytes intestinaux chez le rat. Il est chargé du prélèvement du MI de l'alimentation avec un Km de 150 ± 40 µM. Les analyses fonctionnelles exécutées sur SMIT2 de rat en électrophysiologie après expression dans les ovocytes de Xenopus laevis donnent sensiblement les mêmes résultats que pour les BBMv de rein de lapin et d’intestin de rat. Dans les ovocytes, SMIT2 présente une grande affinité pour le MI (270 ± 19 µM) et le DCI (310 ± 60 µM) et aucune affinité pour le L-fucose. Il est ii également très sensible à la phlorizine (16 ± 7 µM). Une seule exception persiste : la constante d’affinité pour le glucose dans les BBMv d’intestin de rat est 40 fois plus petite que celle observée sur les ovocytes de Xenopus laevis. Nous avons également testé la capacité de certains transporteurs de sucre présents à la surface des membranes apicales des entérocytes à prélever le MI. Vu que l'inhibition de ces transporteurs (SGLT1 et GLUT5) ne changeait rien au taux de MI radioactif transporté, nous en avons conclu qu'ils ne sont pas impliqués dans son transport. Finalement, l’efflux de MI à partir du pôle basolatéral des entérocytes n’est pas effectué par GLUT2 puisque ce dernier lorsqu'il est exprimé dans des ovocytes, est incapable de transporter le MI. / Myo-inositol (MI) is an organic solute involved in various aspects of cell physiology, including cell signaling. It is also known as a compatible osmolyte. Three secondary active MI cotransporters have been identified; two are Na+- coupled (SMIT1 and SMIT2) and one is H+-coupled (HMIT). The main aim of this study was to characterize MI uptake throught SMIT2 as expressed in epithelial cells and in Xenopus laevis oocytes. In order to achieve the characterization of this transport system, we used purified brush border membrane vesicles (BBMv) isolated from rabbit kidney and rat intestine. We first performed a quantification of mRNA levels in rabbit kidney using real time PCR for both SMIT1 and SMIT2. We found that SMIT1 is mainly expressed in the renal medulla while SMIT2 is mainly localized in the renal cortex. This result was confirmed on Western blots using an antibody raised against SMIT2. Through inhibition studies using selective substrates for SMIT1 (inhibited by L-fucose) and SMIT2 (inhibited by D-chiroinositol), we showed that SMIT2 seems to be responsible for all the apical transport of MI into the proximal convoluted tubule with a Km of 57 ± 14 µM. By transport studies we established that rabbit intestine seems to lack apical transport of MI while rat intestine has a very active uptake of this molecule. qRT-PCR quantification confirmed the absence of MI transporters in rabbit intestine. As for kidney, SMIT2 seems to be the only transporter responsible for apical MI uptake in enterocytes with a Km of 150 ± 40 µM. Functional analysis of rat SMIT2 activity, via electrophysiological studies in Xenopus oocytes, demonstrated similarities to the activities of SMIT2 from rat intestine and rabbit kidney. SMIT2 displays high affinities for MI (270 ± 19 µM), DCI (310 ± 60 µM) and no affinity for L-fucose. SMIT2 is very sensitive to phlorizin (Pz; 16 ± 7 µM). Although these functional characteristics essentially confirmed those found in rat intestine, a iv discrepancy exists between the two systems studied. Indeed, the affinity constant for glucose was approximately 40-fold lower in vesicles than in oocytes. We also tested the ability of SGLT1 and GLUT5, other sugar transport systems present in enterocytes apical membranes, to perform MI uptake. Because the inhibition of these transporters did not alter radiolabeled MI uptake, we concluded that they had no significant contribution to MI transport in rat intestine. Finally, the basolateral efflux of MI was not mediated by GLUT2 because when expressed in oocytes, this transporter was not able to transport MI.

Membrane transport processes underlie many purification technologies. The efficiency of a membrane separation process depends upon material throughput (flux), and the degree to which the membrane discriminates amongst species in the feed stock (selectivity). In a supported liquid membrane, flux may be enhanced by carrier molecules, which act as catalysts of translocation. Carrier molecules also confer selectivity, via differential molecular recognition of the substances in the feed stock. The effect of electrical potential on the flux and selectivity of carrier-containing supported liquid membranes is not well documented. We elected to study the effect of electrical potential on supported liquid membranes containing valinomycin, a potassium ionophore, and a calixarene ester, a sodium ionophore. In these systems, the open circuit membrane potential could be made positive or negative by the choice of anion. With both of these carriers, we observed that selectivity for potassium or sodium salts was dependent on the open circuit membrane potential. To confirm that electrical potential was responsible for the observed selectivity variance, we applied a potential across the membrane using a potentiostat. The applied potential created conditions for carrier-mediated electrodialysis, where oxidation and reduction reactions on either side of the membrane act as the driving force for transmembrane flux of charged species. In chronoamperometry experiments, we found that selectivity for potassium or sodium ion was dependent on the applied electrical potential. Subject to some constraints, selectivity and flux could be controlled by the application of positive or negative electrical potentials. Linear sweep voltammetry experiments allowed for the rapid prediction of the potential that must be applied to achieve optimal selectivity. We also found that membrane potential measurements, as well as the magnitude of current that flows in chronoamperometry experiments, could be interpreted to predict Eisenman and Hofmeister sequences. These results are novel, and await a convincing theoretical justification. The results also suggest that a separation technology could be developed around the idea of modulating selectivity with electrical potential. In this regard, carrier-mediated electrodialysis may be suitable for the sequestration of toxic or radioactive heavy metals, and a large number of carrier molecules for metal ions are currently known. The technique may also be suitable for separating organic molecules, such as high-value chiral pharmaceuticals. Supported liquid membranes are a useful research tool, but industrial applications may require a more stable membrane architecture. / Graduate

Diss. (sammanfattning) Uppsala : Uppsala universitet, 2008. / Härtill 6 uppsatser.

Jogo patológico (JP) pode ser definido pela persistência e recorrência do comportamento de apostar em jogos de azar, apesar de prejuízos em diversas áreas da vida decorrentes dessa atividade. O JP é considerado um transtorno do controle de impulso e um modelo de dependência comportamental. Diferentes estudos têm comprovado o envolvimento de vias dopaminérgicas em dependências de substâncias e em jogadores patológicos. O transportador de doamina (DAT) é uma proteína présináptica de neurônios dopaminérgicos nigroestriatais, responsável pela recaptação da dopamina (DA) da fenda sináptica, e tem sido relatada alterações em sua densidade em dependentes de substâncias. O objetivo deste trabalho foi investigar em pacientes com jogo patológico, a densidade de DAT no estriado, através de imagens do exame de SPECT com TRODAT-1- 99mTc verificar por meio de estudo de correlação a associação entre comportamento de jogo (freqüência, tempo, dinheiro, gastos com jogo e fissura/craving) e a densidade DAT em jogadores patológicos. Foram selecionados 15 jogadores e 15 controles normais pareados para gênero, idade e escolaridade. Para inclusão ou exclusão de sujeitos foram utilizados instrumentos de verificação e principais Transtornos Psiquiátricos do Eixo 1 do DSM IV e escalas para depressão e ansiedade; para jogadores patológicos os instrumentos utilizados foram escalas para avaliação do padrão de jogo recente, para avaliação da fissura pelo jogo; para rastreamento de outras dependências comportamentais (sexo e comida). Observou-se que: 1) jogadores patológicos não apresentaram aumento de densidade DAT quando comparados a controles normais; 2) nos jogadores a densidade de DAT foi diretamente proporcional a intensidade de jogo no último mês e inversamente proporcional a auto-eficácia na abstinência do jogo. Não houve correlação significativa entre densidade de DAT e comportamentos de abuso relacionados com sexo ou comida. Desta forma, faz-se necessário estudos futuros para a avaliação da densidade de DAT no início e no fim do tratamento, a fim de verificar se a diminuição da densidade de DAT ao longo do tratamento pode ser utilizada como preditor de boa resposta e bom prognóstico em jogadores patológicos. / Pathological gambling (PG) can be defined by the persistence and recurrence of the behavior of gambling on games of chance, despite losses in many areas of life from this activity. The JP is considered a disorder of impulse control and a model of behavioral dependence. Different studies have demonstrated the involvement of dopaminergic pathways in substance dependency and pathological gamblers. The dopamine transporter (DAT) is a protein pre-synaptic dopaminergic neurons nigroestriatais responsible for the reuptake of dopamine (DA) from the synaptic cleft, and has been reported changes in the density-dependent substances. The objective of this study was to investigate in patients with pathological gambling, the density of DAT in the striatum, through examination of SPECT images with TRODAT-1 - 99mTc to verify through correlation study the association between gambling behavior (frequency, time, money spent on gambling and urge / craving) and DAT density in pathological gamblers. We selected 15 plathological gamblers and 15 controls matched for gender, age and education. For inclusion or exclusion of subjects were used verification tools and major psychiatric disorders in the DSM IV Axis 1 and scales for depression and anxiety; for pathological gamblers were the instruments used scales for assessing the standard of play recently, to evaluate the crack for the game; for tracking other behavioral addictions (sex and food). It was observed that: 1) pathological gamblers did not have increased DAT density compared with normal controls, 2) players in the density of DAT was directly proportional to the intensity of gambling in the last month and inversely proportional to self-efficacy on abstinence of gambling. There was no significant correlation between DAT density and behavior of abuse related to sex or food. Thus, it is necessary to future studies for evaluating the density of DAT at the beginning and end of treatment in order to determine whether the decrease in density during the treatment DAT can be used as predictor of good response and a good prognosis in pathological gamblers.

<p>Supersaturating drug delivery systems are an attractive solubility enabling formulation strategy for poorly soluble drugs due to their potential to significantly enhance solubility and hence, bioavailability. Compendial dissolution testing is commonly used a surrogate for assessing the bioavailability of enabling formulations. However, it increasingly fails to accurately predict <i>in vivo</i> performance due its closed-compartment characteristics and the lack of absorptive sink conditions. <i>In vivo</i>, drug is continually removed due to absorption across the gastrointestinal membrane, which impacts the luminal concentration profile, which in turn affects the dissolution kinetics of any undissolved material, as well as crystallization kinetics from supersaturated solutions. Thus, it is critical to develop an improved methodology that better mimics <i>in vivo</i> conditions. An enhanced approach integrates dissolution and absorption measurements. However, currently-used two-compartment absorptive apparatuses, employing a flat-sheet membrane are limited, in particular by the small membrane surface area that restricts the mass transfer, resulting in unrealistic experimental timeframes. This greatly impacts the suitability of such systems as a formulation development tool. The goal of this research is two-fold. First, to develop and test a high surface area, flow-through, absorptive dissolution testing apparatus, designed to provide <i>in vivo</i> relevant information about formulation performance in biologically relevant time frames. Second, to use this apparatus to obtain mechanistic insight into physical phenomenon occurring during formulation dissolution. Herein, the design and construction of a coupled dissolution-absorption apparatus using a hollow fiber membrane module to simulate the absorption process is described. The hollow fiber membrane offers a large membrane surface area, improving the mass transfer rates significantly. Following the development of a robust apparatus, its application as a formulation development tool was evaluated in subsequent studies. The dissolution-absorption studies were carried out for supersaturated solutions generated via anti-solvent addition, pH-shift and by dissolution of amorphous formulations. The research demonstrates the potential of the apparatus to capture subtle differences between formulations, providing insight into the role of physical processes such as supersaturation, crystallization kinetics and liquid-liquid phase separation on the absorption kinetics. The study also explores dissolution-absorption performance of amorphous solid dispersions (ASDs) and the influence of resultant solution phase behavior on the absorption profile. Residual crystalline content in ASDs is a great concern from a physical stability and dissolution performance perspective as it can promote secondary nucleation or seed crystal growth. Therefore, the risk of drug crystallization during dissolution of ASDs containing some residual crystals was assessed using absorptive dissolution measurements and compared to outcomes observed using closed-compartment dissolution testing. Mesoporous silica-based formulations are another type of amorphous formulations that are gaining increased interest due to higher physical stability and rapid release of the amorphous drug. However, their application may be limited by incomplete drug release resulting from the adsorption tendency of the drug onto the silica surface. Thus, the performance of mesoporous silica-based formulations was also evaluated in the absorptive dissolution testing apparatus to determine the impact of physiological conditions such as gastrointestinal pH and simultaneous membrane absorption on the adsorption kinetics during formulation dissolution. Overall, the aim of this research was to demonstrate the potential of the novel <i>in vitro</i> methodology and highlight the significance of a dynamic absorptive dissolution environment to enable better assessment of complex enabling formulations. <i>In vivo</i>, there are multiple physical processes occurring in the gastrointestinal lumen and the kinetics of these processes strongly depend on the absorption kinetics and <i>vice-a-versa</i>. Thus, using this novel tool, the interplay between solution phase behavior and the likely impacts on bioavailability of supersaturating drug delivery systems can be better elucidated. This approach and apparatus is anticipated to be of great utility to the pharmaceutical industry to make informed decisions with respect to formulation optimization.</p>

Cytokinins are a large group of phytohormones. Since their discovery in the 1950s, they have shown to play a pivotal role in plant physiology. Most studies so far focused on cytokinin action mechanisms and their metabolic regulation. Identification of AtABCG14 and AtPUP14 as cytokinin-specific membrane carriers brought researchers' attention to cytokinin membrane transport, too. In this thesis, we performed experiments with radio-labelled cytokinin tracers. We show that trans-zeatin and isopentenyladenine, two major biologically active cytokinins, are readily transported across the plasma membrane in tobacco BY-2 cell suspension. Making use of mathematical modelling, we show that BY-2 cells possess a membrane transport system with an affinity toward cytokinins. Next, we show that atabcg14 and atpup14 mutations affect cytokinin metabolism in Arabidopsis thaliana plants. Keywords: cytokinin, Arabidopsis thaliana, tobacco BY-2 cell lines, membrane transport, purine permease, ATP-binding cassette, radio-labelling

A alteração do tráfego mitocondrial em neurônios leva ao aumento do estresse oxidativo, privação de energia, deficiência da comunicação intercelular e neurodegeneração. Há evidências de que essas alterações de tráfego antecedem a morte neuronal associada à agregação proteica. Portanto, conhecer a relação entre a mobilidade mitocondrial e a formação de agregados proteicos pode ser um passo importante para o melhor entendimento dos mecanismos da neurodegeneração. Com isso, o objetivo do presente estudo é analisar a mobilidade das mitocôndrias em culturas de células do hipocampo, substância negra e locus coeruleus expostas a rotenona e MPTP, como agentes neurodegenerativos, e à rapamicina como ativador da autofagia. Um outro objetivo do estudo é avaliar o papel do cálcio (através do emprego de EGTA e ionomicina) no modelo experimental. Os resultados mostraram aumento da mobilidade mitocondrial no hipocampo e diminuição na substância negra, já no locus coeruleus houve aumento seguido de diminuição da mobilidade mitocondrial dependendo da concentração de rotenona. O emprego do EGTA e ionomicina mostra que a ação da rotenona sobre o tráfego mitocondrial envolve o cálcio, mas não se relaciona com uma possível alteração da integridade mitocondrial, já que não foi observada alteração no potencial de membrana mitocondrial. Foram também realizados experimentos a fim de avaliar a mobilidade mitocondrial em modelo utilizando rapamicina para ativar a autofagia e MPTP como indutor da neurodegeneração em culturas de células, onde foi observado aumento da mobilidade no hipocampo e no locus coeruleus quando exposto a rapamicina e aumento da mobilidade mitocondrial em cultura de células do hipocampo exposto a MPTP já no locus coeruleus houve uma diminuição significativa da mobilidade mitocondrial. Os resultados permitem concluir que o tráfego mitocondrial está alterado antes da agregação proteica podendo contribuir com a neurodegeneração / Altered mitochondrial traffic in neurons can lead to increased oxidative stress, energy deprivation, impaired intercellular communication and neurodegeneration. There are evidences mitochondria disturbing precedes neuronal death associated with protein aggregation. Therefore, the study of mitochondrial traffic and protein aggregation can be an important step towards a better understanding of the mechanisms of neurodegeneration. Thus, the aim of this study is to analyze mitochondria mobility in cultured cells of the hippocampus, substantia nigra and locus coeruleus exposed to rotenone and MPTP, as neurodegeneration-promoting agents, and rapamycin to activate autophagy. The other objective of the study was to analyze the role of calcium (through EGTA and ionomycin) in the experimental model. The results showed increased and decreased mobility mitochondrial in cells from hippocampus and substantia nigra, respectively, while the locus coeruleus cell culture has increased followed by decreased mitochondrial mobility depending upon rotenone concentration. The use of EGTA and ionomycin showed that alteration of mitochondrial traffic is associated with calcium, however it is not related with changes in mitochondrial membrane potential. Additional experiments were also conducted to assess mitochondrial mobility in a model using rapamycin to activate autophagy and MPTP to induce neurodegeneration in cell cultures. The results of these experiments showed increased mitochondrial mobility in the hippocampus and locus coeruleus when exposed to rapamycin; while MPTP also increased mitochondria mobility in hippocampal cell cultures, but decreased it in locus coeruleus. Results suggest that mitochondrial traffic is altered before protein aggregation, which may contribute to neurodegeneration

A alteração do tráfego mitocondrial em neurônios leva ao aumento do estresse oxidativo, privação de energia, deficiência da comunicação intercelular e neurodegeneração. Há evidências de que essas alterações de tráfego antecedem a morte neuronal associada à agregação proteica. Portanto, conhecer a relação entre a mobilidade mitocondrial e a formação de agregados proteicos pode ser um passo importante para o melhor entendimento dos mecanismos da neurodegeneração. Com isso, o objetivo do presente estudo é analisar a mobilidade das mitocôndrias em culturas de células do hipocampo, substância negra e locus coeruleus expostas a rotenona e MPTP, como agentes neurodegenerativos, e à rapamicina como ativador da autofagia. Um outro objetivo do estudo é avaliar o papel do cálcio (através do emprego de EGTA e ionomicina) no modelo experimental. Os resultados mostraram aumento da mobilidade mitocondrial no hipocampo e diminuição na substância negra, já no locus coeruleus houve aumento seguido de diminuição da mobilidade mitocondrial dependendo da concentração de rotenona. O emprego do EGTA e ionomicina mostra que a ação da rotenona sobre o tráfego mitocondrial envolve o cálcio, mas não se relaciona com uma possível alteração da integridade mitocondrial, já que não foi observada alteração no potencial de membrana mitocondrial. Foram também realizados experimentos a fim de avaliar a mobilidade mitocondrial em modelo utilizando rapamicina para ativar a autofagia e MPTP como indutor da neurodegeneração em culturas de células, onde foi observado aumento da mobilidade no hipocampo e no locus coeruleus quando exposto a rapamicina e aumento da mobilidade mitocondrial em cultura de células do hipocampo exposto a MPTP já no locus coeruleus houve uma diminuição significativa da mobilidade mitocondrial. Os resultados permitem concluir que o tráfego mitocondrial está alterado antes da agregação proteica podendo contribuir com a neurodegeneração / Altered mitochondrial traffic in neurons can lead to increased oxidative stress, energy deprivation, impaired intercellular communication and neurodegeneration. There are evidences mitochondria disturbing precedes neuronal death associated with protein aggregation. Therefore, the study of mitochondrial traffic and protein aggregation can be an important step towards a better understanding of the mechanisms of neurodegeneration. Thus, the aim of this study is to analyze mitochondria mobility in cultured cells of the hippocampus, substantia nigra and locus coeruleus exposed to rotenone and MPTP, as neurodegeneration-promoting agents, and rapamycin to activate autophagy. The other objective of the study was to analyze the role of calcium (through EGTA and ionomycin) in the experimental model. The results showed increased and decreased mobility mitochondrial in cells from hippocampus and substantia nigra, respectively, while the locus coeruleus cell culture has increased followed by decreased mitochondrial mobility depending upon rotenone concentration. The use of EGTA and ionomycin showed that alteration of mitochondrial traffic is associated with calcium, however it is not related with changes in mitochondrial membrane potential. Additional experiments were also conducted to assess mitochondrial mobility in a model using rapamycin to activate autophagy and MPTP to induce neurodegeneration in cell cultures. The results of these experiments showed increased mitochondrial mobility in the hippocampus and locus coeruleus when exposed to rapamycin; while MPTP also increased mitochondria mobility in hippocampal cell cultures, but decreased it in locus coeruleus. Results suggest that mitochondrial traffic is altered before protein aggregation, which may contribute to neurodegeneration

No description available.